Redesigning follow-up care for cancer patients
Art & Science Previous     Next

Redesigning follow-up care for cancer patients

Sarah Burton Macmillan lead gynaecological oncology clinical nurse specialist, Velindre Cancer Centre, Cardiff
Lisa Miller Director of operations, Velindre Cancer Centre, Cardiff
Clare Churcher Gynaecological oncology clinical nurse specialist, Velindre Cancer Centre, Cardiff
Louise Hanna Consultant clinical oncologist, Velindre Cancer Centre, Cardiff
Rachel Jones Consultant medical oncologist, Velindre Cancer Centre, Cardiff
Emma Hudson Consultant clinical oncologist, Velindre Cancer Centre, Cardiff
Mark Bray Senior account manager, Pfizer
Geoff Rollason Programme director, Pfizer Health Solutions
Rowena Cornell Project manager, Pfizer Health Solutions

Sarah Burton and colleagues describe how introducing nurse-led and telephone consultations has improved patient satisfaction and reduced referrals to consultants

The role of specialist oncology nurses has developed significantly in recent years with new ways of working. This article describes a partnership project between a large cancer centre and a pharmaceutical company that resulted in the establishment of specialist nurse-led survivorship clinics as part of a follow-up pathway for patients with ovarian cancer. The reduced need for consultant-led follow up and the favourable feedback from patients support the need for oncology nurses to increase their profile in clinics.

Cancer Nursing Practice. 12, 6,12-17. doi: 10.7748/cnp2013.07.12.6.12.e931

Correspondence

sarah.burton@wales.nhs.uk

Peer review

This article has been subject to double blind peer review.

Conflict of interest

Mark Bray is employed by Pfizer; Geoff Rollason and Rowena Cornell are employed by Pfizer Health Solutions. Pfizer provided funding for the employment of a medical writer for the first draft of the article

Received: 13 November 2012

Accepted: 07 March 2013